Where a company has multiple ethical concerns, the total concerns percentage counts this investment once.
The average total concerns of all funds of the same risk profile is weighted by the funds' investment values.
The average total concerns of all managed aggressive funds is 12.02%.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
Where companies are involved in the production or distribution of chemicals which are highly hazardous to human or environmental health including herbicides, pesticides and PFAS.
Where companies are involved in the manufacturing or retail of controversial weapons (e.g., landmines and cluster munitions) or components or services thereof.
Where companies are involved in the manufacturing or retail of firearms, including guns, rifles, pistols, or components or services thereof.
Where companies derive revenue from the manufacturing of weapons or weapon components and services to the defence industry. We do not include non-weapons-related military support.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
Where companies are involved in the production or distribution of chemicals which are highly hazardous to human or environmental health including herbicides, pesticides and PFAS.
The Pie Global Growth Fund seeks to provide investors with long term capital growth by investing predominantly in listed Smaller Companies globally. The fund may also invest in managed funds with similar characteristics to Pie Funds.
| Value | $240M NZD |
| Period of data report | 31st March 2025 |
| Fund started | 2nd Sept. 2013 |
| Total annual fund fees | 1.58% |
| Total performance based fees | 0.0% |
| Manager's basic fee | 1.45% |
| Other management and administration charges | 0.13% |
| Total other charges | 0.0 |
| Total other charges currency | NZD |
|
Michael Taylor |
Currently: Executive Director and Chief Investment Officer (3 years, 0 months)
|
|
Guy Thornewill |
Currently: Head of Global Research (6 years, 8 months)
|
|
Toby Woods |
Currently: Senior Investment Analyst (5 years, 7 months)
|
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.
| Year | Market Average | Fund Annual Return |
|---|---|---|
| 2025 | 4.07% | -9.88% |
| 2024 | 15.78% | 6.03% |
| 2023 | -4.85% | 3.14% |
| 2022 | 3.53% | -0.45% |
| 2021 | 35.55% | 41.57% |
| 2020 | -7.06% | 3.49% |
| 2019 | 10.17% | 1.91% |
| 2018 | 7.53% | 15.14% |
| 2017 | 9.49% | 14.12% |
| 2016 | 4.71% | 1.05% |
The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
William Blair Sicav Fund
United States Australasian Equities
Cbiz Inc
United States International Equities
Merit Medical Systems Inc
United States International Equities
National Vision Holdings Inc
United States International Equities
Colliers International Group Inc
United States Listed Property
Advanced Energy Industries Inc
United States International Equities
Hillman Solutions Corp
United States International Equities
Ishares U.S. Regional Banks Et
United States International Equities
Century Pacific Food Inc
Philippines International Equities
Radnet Inc
United States International Equities
| Type | Target | Actual |
|---|---|---|
| Cash and Cash Equivalents | 0.0% | 12.06% |
| New Zealand Fixed Interest | 0.0% | 0.0% |
| International Fixed Interest | 0.0% | 0.0% |
| Australasian Equities | 0.0% | 0.0% |
| International Equities | 100.0% | 83.54% |
| Listed Properties | 0.0% | 4.4% |
| Unlisted Properties | 0.0% | 0.0% |
| Other | 0.0% | 0.0% |
| Commodities | 0.0% | 0.0% |
How the money in this fund is invested by asset type.
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
This data is compiled by Mindful Money from the fund information and portfolios
that each
fund has
filed with the Disclose register to 31st March 2025 and Mindful Money
analysis of funds within those portfolios. The list of companies of concern has
been drawn from ratings agencies and public sources, including the Norwegian
Sovereign Fund, NZ Super Fund, Sustainalytics and research organisations.
Please note that companies may breach more than one of these areas of
concern.
The listing of companies of concern is based on definitions used in Mindful Money's
methodology. These definitions may
be different from the exclusions policy and definitions applied by the fund provider.
Mindful Money uses the term Mindful Funds as our standard
for ethical investment and responsible investment. This does not imply that
other funds are unethical or that the fund providers that do not meet these
standards are unethical providers.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
Where companies are involved in the production or distribution of chemicals which are highly hazardous to human or environmental health including herbicides, pesticides and PFAS.
Where companies are involved in the manufacturing or retail of controversial weapons (e.g., landmines and cluster munitions) or components or services thereof.
Where companies are involved in the manufacturing or retail of firearms, including guns, rifles, pistols, or components or services thereof.
Where companies derive revenue from the manufacturing of weapons or weapon components and services to the defence industry. We do not include non-weapons-related military support.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
Where companies are involved in the production or distribution of chemicals which are highly hazardous to human or environmental health including herbicides, pesticides and PFAS.
The Pie Global Growth Fund seeks to provide investors with long term capital growth by investing predominantly in listed Smaller Companies globally. The fund may also invest in managed funds with similar characteristics to Pie Funds.
| Value | $240M NZD |
| Period of data report | 31st March 2025 |
| Fund started | 2nd Sept. 2013 |
| Total annual fund fees | 1.58% |
| Total performance based fees | 0.0% |
| Manager's basic fee | 1.45% |
| Other management and administration charges | 0.13% |
| Total other charges | 0.0 |
| Total other charges currency | NZD |
|
Michael Taylor |
Currently: Executive Director and Chief Investment Officer (3 years, 0 months)
|
|
Guy Thornewill |
Currently: Head of Global Research (6 years, 8 months)
|
|
Toby Woods |
Currently: Senior Investment Analyst (5 years, 7 months)
|
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.
| Year | Market Average | Fund Annual Return |
|---|---|---|
| 2025 | 4.07% | -9.88% |
| 2024 | 15.78% | 6.03% |
| 2023 | -4.85% | 3.14% |
| 2022 | 3.53% | -0.45% |
| 2021 | 35.55% | 41.57% |
| 2020 | -7.06% | 3.49% |
| 2019 | 10.17% | 1.91% |
| 2018 | 7.53% | 15.14% |
| 2017 | 9.49% | 14.12% |
| 2016 | 4.71% | 1.05% |
The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
William Blair Sicav Fund
United States Australasian Equities
Cbiz Inc
United States International Equities
Merit Medical Systems Inc
United States International Equities
National Vision Holdings Inc
United States International Equities
Colliers International Group Inc
United States Listed Property
Advanced Energy Industries Inc
United States International Equities
Hillman Solutions Corp
United States International Equities
Ishares U.S. Regional Banks Et
United States International Equities
Century Pacific Food Inc
Philippines International Equities
Radnet Inc
United States International Equities
| Type | Target | Actual |
|---|---|---|
| Cash and Cash Equivalents | 0.0% | 12.06% |
| New Zealand Fixed Interest | 0.0% | 0.0% |
| International Fixed Interest | 0.0% | 0.0% |
| Australasian Equities | 0.0% | 0.0% |
| International Equities | 100.0% | 83.54% |
| Listed Properties | 0.0% | 4.4% |
| Unlisted Properties | 0.0% | 0.0% |
| Other | 0.0% | 0.0% |
| Commodities | 0.0% | 0.0% |
How the money in this fund is invested by asset type.
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
